Latest Blogs

Jan 15, 2021
In this new year we must remain alert to our own prejudices, and be vigilant about keeping our personal biases out of the charts and out of our discussions with colleagues, patients, and caregivers. 
Jan 15, 2021
It was clear to chief medical officer Dr. Richard L. Schilsky that ASCO would be his professional home throughout his career. He shares reflections on the role of the Society ahead of his retirement, after 8 years as CMO, in February.
Jan 12, 2021
"It is far too common that patients with less access to care or different skin color or unfamiliar language are assumed to not understand," writes Dr. Jacquelyne Gaddy. "Maybe it is in fact that we didn’t take the time to understand."
Jan 11, 2021
Feeling the mid-academic year slump? Here are a few tips based on my own ongoing attempts to strike a balance between my clinical duties and my scholarly activities during fellowship. 
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

May 05, 2010
It seems like I've participated in every facet of the "ASCO guideline" process. During the past three years of being part of the HSC (now CPG) committee, I have been amazed to witness how complex and detailed developing a guideline can become. The manuscripts are reviewed at several levels and...

Pages